07/09/2021 (Agence Europe) – Although it does not consider an additional dose of Covid-19 vaccine (see EUROPE B12782A22) to be “urgent” for the general population, the European Medicines Agency (EMA) announced, on Monday 6 September, that it will soon make a decision on the use of a third dose of the Pfizer/BioNTech vaccine. The agency says it will review data submitted by the company on the subject, including “the results from an ongoing clinical trial in which around 300 adults...